High-Dose Cyclophosphamide and Tacrolimus as Graft-versus-Host Disease Prophylaxis for Matched and Mismatched Unrelated Donor Transplantation-Reference-Cited by-同舟云学术

High-Dose Cyclophosphamide and Tacrolimus as Graft-versus-Host Disease Prophylaxis for Matched and Mismatched Unrelated Donor Transplantation

Published:2021-07 Issue:7 Volume:27 Page:619.e1-619.e8
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Pedraza Alexandra,Jorge Sofia,Suárez-Lledó María,Pereira Arturo,Gutiérrez-García Gonzalo,Fernández-Avilés Francesc,Rosiñol Laura,Llobet Noemí,Solano Teresa,Urbano-Ispízua Álvaro,Rovira Montserrat,Martínez Carmen

Funder

Fundación Josep Carreras Contra la Leucemia

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference24 articles.

1. Impact of HLA-mismatch in unrelated donor hematopoietic stem cell transplantation: a meta-analysis;Kekre;Am J Hematol,2016

2. High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism;Kawase;Blood,2007

3. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation;Lee;Blood,2007

4. Limits of HLA mismatching in unrelated hematopoietic cell transplantation;Petersdorf;Blood,2004

5. The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy;Kollman;Blood,2016

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of older adults undergoing allogeneic hematopoietic cell transplantation with post‐transplant cyclophosphamide based prophylaxis;European Journal of Haematology;2024-08-14

2. Safety and efficacy of G-CSF after allogeneic hematopoietic cell transplantation using post-transplant cyclophosphamide: clinical and in vitro examination of endothelial activation;Bone Marrow Transplantation;2024-08-08

3. Lower incidence of acute graft-versus-host disease with post-transplantation cyclophosphamide compared to anti-thymocyte globulin in higher-risk myelodysplastic syndrome;Bone Marrow Transplantation;2024-07-08

4. Combination of reduced post‐transplant cyclophosphamide and early tacrolimus initiation increases the incidence of chronic graft‐versus‐host disease in human leukocyte antigen‐haploidentical peripheral blood stem‐cell transplantation;eJHaem;2024-06-19

5. The state of the art in the treatment of severe aplastic anemia: immunotherapy and hematopoietic cell transplantation in children and adults;Frontiers in Immunology;2024-04-05